Author

Y. Mosesson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

A. Audia· 1 shared A. Bakayoko· 1 shared A. E. Goen· 1 shared A. Jiang· 1 shared A. L. Johnson· 1 shared A. M. Roberts· 1 shared A. Wesa· 1 shared B. A. Romo· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Audia

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Estrogen therapy induces receptor-dependent DNA damage enhanced by PARP inhibition in ER+ breast cancer

N. A. Traphagen, G. N. Schwartz, S. Tau, A. Jiang, S. R. Hosford, A. E. Goen, A. M. Roberts, B. A. Romo, A. L. Johnson, E.-C. K. Duffy, E. Demidenko, P. Heverly, Y. Mosesson, S. M. Soucy, F. Kolling, T. W. Miller

This study shows estrogen therapy induces DNA damage in ER+ breast cancer cells, which can be enhanced by PARP inhibition to improve treatment outcomes.

bioRxiv · Mar 16, 2023Cancer Biology

Pharmaco-Pheno-Multiomic Integration Reveals Biomarker Profiles and Therapeutic Response Prediction Models in Leukemia and Ovarian Cancer

G. Silberberg, B. Walling, A. Wesa, A. Audia, I. Sloma, Y. Zeng, G. Han, J. Tabg, P. Pammer, A. Bakayoko, X. Ren, D. Ciznadija, X. Ren, B. Vishwakarma, Y. Mosesson, , M. RItchie

This study integrates multi-omic and phenotypic data to predict therapeutic response in leukemia and ovarian cancer, identifying biomarker profiles and mechanisms of resistance.

bioRxiv · Jun 14, 2022Cancer Biology